论文部分内容阅读
目的探究给予冠心病慢性心力衰竭患者经皮冠状动脉介入治疗的临床疗效与安全性。方法:选择2015年1月-2015年12月医院收治的42例冠心病慢性心力衰竭患者为研究对象,均行经皮冠状动脉介入治疗。分析患者冠脉靶血管特点,测量并记录患者手术前后心功能改变情况,统计患者并发症发生情况。结果:42例患者经皮冠状动脉治疗均成功,手术成功率100%;冠状动脉造影显示,7例患者单支冠脉病变,23例两支冠脉病变,12例三支冠脉病变,分别占病例总数的16.67%、54.76%和28.57%;病变累及前降支33例,累及右冠状动脉26例,累及回旋支18例,累及左冠状动脉主干6例;患者治疗前后各项心功能指标较治疗前均有明显改善,差异有统计学意义(P<0.05);围手术期内出现3例并发症(1例假性动脉瘤,1例心室颤动,1例腹股沟血肿),并发症发生率7.14%。结论:给予冠心病慢性心力衰竭患者经皮冠状动脉介入治疗可明显改善患者心功能,缓解患者临床病症,并发症发生风险较低,应用安全有效,之的临床推广。
Objective To investigate the clinical efficacy and safety of percutaneous coronary intervention in patients with chronic heart failure and coronary heart disease. Methods: From January 2015 to December 2015, 42 patients with chronic heart failure of coronary heart disease admitted to our hospital were selected as the study subjects, all underwent percutaneous coronary intervention. Analysis of coronary artery target vessel characteristics, measurement and recording of patients with changes in cardiac function before and after surgery, statistics of patient complications. Results: All the 42 patients were successfully treated by percutaneous coronary intervention. The success rate of operation was 100%. Coronary angiography showed that in 7 patients single coronary artery disease, 23 two coronary artery disease and 12 three coronary artery disease were involved. Accounting for 16.67%, 54.76% and 28.57% of the total number of cases; lesions involving anterior descending artery in 33 cases, involving the right coronary artery in 26 cases, involving the circumflex artery in 18 cases, involving the left main coronary artery in 6 cases; before and after treatment of cardiac function indicators Compared with before treatment were significantly improved, the difference was statistically significant (P <0.05); perioperative complications occurred in 3 cases (1 case of pseudoaneurysm, 1 case of ventricular fibrillation, 1 case of groin hematoma), the incidence of complications 7.14%. Conclusion: Percutaneous coronary intervention in patients with chronic heart failure of coronary heart disease can significantly improve the patient’s cardiac function, relieve the clinical symptoms, the risk of complications is low, the application of safe and effective, the clinical promotion.